ARTICLE | Clinical News
Soliris eculizumab regulatory update
April 20, 2015 7:00 AM UTC
The European Commission approved an expanded label for Soliris eculizumab from Alexion to include transfusion-naive paroxysmal nocturnal hemoglobinuria (PNH) patients with high disease activity. Previ...